Concepedia

Julie Dang

JD

31

Publications

3.7K

Citations

24

H-Index

2008

Active since

Affiliations

University of California, Los Angeles(Current)

University of California, Davis

University of California, San Francisco

UC Davis Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

Julie Dang is an author at University of California, Los Angeles specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2008–2024

31

Publications

31

Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu et al. · PLoS Medicine · 2008 · 585 citations · Full text

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Deliang Guo, Felicia Reinitz, Mary Youssef et al. · Cancer Discovery · 2011 · 435 citations · Full text

, , +16

Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

Igor Vivanco, H. Ian Robins, Daniel Rohle et al. · Cancer Discovery · 2012 · 336 citations · Full text

EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy

Deliang Guo, Robert M. Prins, Julie Dang et al. · Science Signaling · 2009 · 335 citations · Full text

Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

Kazuhiro Tanaka, Ivan Babić, David A. Nathanson et al. · Cancer Discovery · 2011 · 278 citations · Full text

Rows per page

1–5 of 31